We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$27.1B
AUM Growth
+$3.44B
Cap. Flow
+$921M
Cap. Flow %
3.4%
Top 10 Hldgs %
34.67%
Holding
1,351
New
69
Increased
716
Reduced
273
Closed
50

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$162M
2
SBAC icon
SBA Communications
SBAC
+$111M
3
ESS icon
Essex Property Trust
ESS
+$96.7M
4
MAA icon
Mid-America Apartment Communities
MAA
+$92.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$75.9M

Top Sells

Rank Stock Value
1
OHI icon
Omega Healthcare
OHI
+$137M
2
AMT icon
American Tower
AMT
+$116M
3
PSA icon
Public Storage
PSA
+$97.9M
4
UDR icon
UDR
UDR
+$80.4M
5
AVB icon
AvalonBay Communities
AVB
+$73.9M

Sector Composition

Rank Sector Weight
1 Real Estate 30.73%
2 Technology 27.75%
3 Communication Services 10.3%
4 Consumer Discretionary 6.75%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUPN icon
1126
Supernus Pharmaceuticals
SUPN
$2.77B
$7K ﹤0.01%
209
– –
VCEL icon
1127
Vericel Corp
VCEL
$2.39B
$7K ﹤0.01%
163
– –
VCYT icon
1128
Veracyte
VCYT
$4.44B
$7K ﹤0.01%
266
– –
XLK icon
1129
State Street Technology Select Sector SPDR ETF
XLK
$112B
$7K ﹤0.01%
54
-16
-23% -$1.78K
ZLAB icon
1130
Zai Lab
ZLAB
$2.1B
$7K ﹤0.01%
193
-10,871
-98% -$357K
GRAL
1131
GRAIL Inc
GRAL
$2.76B
$7K ﹤0.01%
129
+31
+32% +$1.12K
ADPT icon
1132
Adaptive Biotechnologies
ADPT
$3.6B
$6K ﹤0.01%
530
– –
ARQT icon
1133
Arcutis Biotherapeutics
ARQT
$3.55B
$6K ﹤0.01%
439
– –
BCRX icon
1134
BioCryst Pharmaceuticals
BCRX
$2.48B
$6K ﹤0.01%
692
– –
FOLD
1135
DELISTED
Amicus Therapeutics
FOLD
$6K ﹤0.01%
986
– –
HRMY icon
1136
Harmony Biosciences
HRMY
$2.07B
$6K ﹤0.01%
189
– –
IRON icon
1137
Disc Medicine
IRON
$2.85B
$6K ﹤0.01%
113
– –
NVCR icon
1138
NovoCure
NVCR
$1.89B
$6K ﹤0.01%
357
– –
OCUL icon
1139
Ocular Therapeutix
OCUL
$1.85B
$6K ﹤0.01%
593
– –
SPRY icon
1140
ARS Pharmaceuticals
SPRY
$563M
$6K ﹤0.01%
367
– –
TARS icon
1141
Tarsus Pharmaceuticals
TARS
$2.57B
$6K ﹤0.01%
137
– –
USIG icon
1142
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
$6K ﹤0.01%
+113
New +$5.71K
XLI icon
1143
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
$6K ﹤0.01%
38
– –
ANIP icon
1144
ANI Pharmaceuticals
ANIP
$1.84B
$5K ﹤0.01%
70
– –
ETNB
1145
DELISTED
89bio
ETNB
$5K ﹤0.01%
499
– –
EWTX icon
1146
Edgewise Therapeutics
EWTX
$4.34B
$5K ﹤0.01%
344
– –
GPCR icon
1147
Structure Therapeutics
GPCR
$3.4B
$5K ﹤0.01%
226
– –
INVA icon
1148
Innoviva
INVA
$1.61B
$5K ﹤0.01%
238
– –
XLC icon
1149
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
$5K ﹤0.01%
42
– –
ABCL icon
1150
AbCellera Biologics
ABCL
$1.62B
$4K ﹤0.01%
1,151
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2025 Portfolio in Review

As of Q2 2025, Daiwa Securities Group held 1,351 positions worth $27.1B, up 15% from $23.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $921M of net new capital in Q2 2025, opening 69 new positions and adding to 716 existing holdings. Its largest new stake was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.

By sector, the portfolio is most concentrated in Real Estate at 31% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Omega Healthcare, an estimated $137M trimmed.

  • Daiwa Securities Group's largest Q2 2025 buy was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.
  • Daiwa Securities Group added most to Apple in Q2 2025, an estimated $162M increase.
  • Daiwa Securities Group's biggest Q2 2025 reduction was Omega Healthcare, cutting an estimated $137M.
  • Daiwa Securities Group fully exited iShares Core US Aggregate Bond ETF in Q2 2025, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $27.1B portfolio in Q2 2025.
  • Daiwa Securities Group opened 69 new positions and closed 50 in Q2 2025.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $27.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2025, filed 14 Aug 2025.